Healthcare company GoodRx went public yesterday and its shares closed 50% higher than its initial price of $33, giving the company a valuation of $19.4b. The company – which offers price comparison for drugs and coupons to lower the price of medicines – raised $1b through the IPO.
- In its filing, the company said: "18 million customers could not have afforded to fill their prescriptions without the savings provided by GoodRx."
- The company has been profitable since 2016 and reported revenue of $257m for H1 2020, up 48% from last year. The company had a valuation of $2.8b in 2018.
- GoodRx acquired telemedicine provider HeyDoctor in September 2019.